MGUS
Clinical trials for MGUS explained in plain language.
Never miss a new study
Get alerted when new MGUS trials appear
Sign up with your email to follow new studies for MGUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can tracking a precancerous condition slash myeloma diagnosis delays?
Knowledge-focused Recruiting nowThis study follows 2,000 people with monoclonal gammopathy of undetermined significance (MGUS), a condition that can precede multiple myeloma, a rare blood cancer. The goal is to measure how often MGUS progresses to myeloma and to understand current monitoring practices. Particip…
Matched conditions: MGUS
Sponsor: Oxford University Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Sugar coating may be key to rare disease diagnosis
Knowledge-focused Recruiting nowThis study investigates how a sugar modification called N-glycosylation affects AL amyloidosis, a rare disease where abnormal proteins build up in organs. Researchers will analyze blood and bone marrow samples from 100 adults with related conditions to better understand the disea…
Matched conditions: MGUS
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Massive biobank launches to unlock myeloma mysteries
Knowledge-focused Recruiting nowThis study collects and stores blood and tissue samples from 6,000 people with multiple myeloma and related conditions like smoldering myeloma and MGUS. The goal is to create a shared resource for researchers worldwide to study these diseases and improve patient care. Participant…
Matched conditions: MGUS
Sponsor: European Myeloma Network B.V. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC